PL443102A1 - Nowa pochodna azetydyno-2,4-dionu, sposób otrzymywania nowej pochodnej azetydyno-2,4-dionu i zastosowanie nowej pochodnej azetydyno-2,4-dionu - Google Patents

Nowa pochodna azetydyno-2,4-dionu, sposób otrzymywania nowej pochodnej azetydyno-2,4-dionu i zastosowanie nowej pochodnej azetydyno-2,4-dionu

Info

Publication number
PL443102A1
PL443102A1 PL443102A PL44310222A PL443102A1 PL 443102 A1 PL443102 A1 PL 443102A1 PL 443102 A PL443102 A PL 443102A PL 44310222 A PL44310222 A PL 44310222A PL 443102 A1 PL443102 A1 PL 443102A1
Authority
PL
Poland
Prior art keywords
dione derivative
new azetidine
azetidine
new
obtaining
Prior art date
Application number
PL443102A
Other languages
English (en)
Other versions
PL249026B1 (pl
Inventor
Krzysztof Zbigniew Łączkowski
Beata Donarska
Original Assignee
Uniwersytet Mikołaja Kopernika W Toruniu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Mikołaja Kopernika W Toruniu filed Critical Uniwersytet Mikołaja Kopernika W Toruniu
Priority to PL443102A priority Critical patent/PL249026B1/pl
Publication of PL443102A1 publication Critical patent/PL443102A1/pl
Publication of PL249026B1 publication Critical patent/PL249026B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Przedmiotem wynalazku jest nowa pochodna azetydyno-2,4-dionu, sposób otrzymywania nowej pochodnej azetydyno-2,4-dionu i zastosowanie nowej pochodnej azetydyno-2,4-dionu.
PL443102A 2022-12-09 2022-12-09 Pochodna azetydyno-2,4-dionu, sposób jej otrzymywania i zastosowanie PL249026B1 (pl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL443102A PL249026B1 (pl) 2022-12-09 2022-12-09 Pochodna azetydyno-2,4-dionu, sposób jej otrzymywania i zastosowanie

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL443102A PL249026B1 (pl) 2022-12-09 2022-12-09 Pochodna azetydyno-2,4-dionu, sposób jej otrzymywania i zastosowanie

Publications (2)

Publication Number Publication Date
PL443102A1 true PL443102A1 (pl) 2023-05-15
PL249026B1 PL249026B1 (pl) 2026-02-23

Family

ID=86325368

Family Applications (1)

Application Number Title Priority Date Filing Date
PL443102A PL249026B1 (pl) 2022-12-09 2022-12-09 Pochodna azetydyno-2,4-dionu, sposób jej otrzymywania i zastosowanie

Country Status (1)

Country Link
PL (1) PL249026B1 (pl)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113423701A (zh) * 2018-11-13 2021-09-21 拜欧斯瑞克斯公司 取代的异吲哚啉酮
US20230045737A1 (en) * 2018-12-05 2023-02-09 Vividion Therapeutics, Inc. Substituted isoindolinones as modulators of cereblon-mediated neo-substrate recruitment
TWI851729B (zh) * 2019-05-31 2024-08-11 美商西建公司 經取代1-氧代-異吲哚啉-5-羧醯胺化合物，其組成物，及以此治療之方法

Also Published As

Publication number Publication date
PL249026B1 (pl) 2026-02-23

Similar Documents

Publication Publication Date Title
MX2022007527A (es) Inhibidores de proteinas kras mutantes.
CL2021002880S1 (es) Estuche de auriculares. (divisional solicitud 202000595)
PH12021553018A1 (en) New egfr inhibitors
MX2023014154A (es) Anticuerpos anti-ccr8.
CL2021002167A1 (es) Síntesis de omecamtiv mecarbil (divisional de la solicitud no. 201903898)
MX2020007947A (es) Inhibidores de erbb/btk.
JOP20230170A1 (ar) مثبطات cdk2 وطرق لاستخدامها
MX2021008400A (es) Inhibidores de dihidroorotato deshidrogenasa.
BR112022003357A2 (pt) Compostos heterocíclicos
CL2025002377A1 (es) Polimorfo como inhibidor de la proteína quinasa mek, método de preparación y uso del mismo
MX2021015842A (es) Polipeptido variante de dihidrodipicolinato reductasa y procedimiento de produccion de l-treonina mediante el uso del mismo.
GEAP202416390A (en) Bicyclic heteroaromatic inhibitors of klk5
CL2021000663A1 (es) Proceso para la producción de gas de síntesis.
ZA202106519B (en) Caspase inhibitors and methods of use thereof
CO2025005303A2 (es) Método para preparar maribavir
PH12023550112A1 (en) Anti-notch2 antibodies and methods of use
JOP20230205A1 (ar) مثبطات vmat2 وطرق لاستخدامها
CL2024003050A1 (es) Método e intermediario para la preparación de apalutamida.
MA70825B1 (fr) Traitement de douleur associée à la sensibilisation centrale
PL437991A1 (pl) Sposób izolacji i hodowli szczepów, szczepy, ich zastosowanie, podłoże do ich hodowli oraz forma scytoneminy
WO2022261534A3 (en) Three-dimensional cell-laden bioink scaffolds and methods of making the same under cryogenic conditions for tissue engineering
PL448768A1 (pl) Związek stanowiący pochodną C20-aminosalinomycyny i sposób jego otrzymywania
MX2021008102A (es) Composicion para el diagnostico o tratamiento de condiciones asociadas con actividad aumentada del factor de iniciacion de traduccion eucariotica 4e (eif4e) que comprende un inhibidor de eif4e.
UY5223S (es) Ornamento
CA221413S (fr) Bague